Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Novo Nordisk's Biggest Strength and Weakness

Many big pharma companies, like Eli Lilly (NYSE: LLY  ) and Merck, embrace the strategy of diversification. Both companies not only market medications for a wide range of diseases, but they also sell animal health products. Merck also has a large consumer health division, which sells products like Coppertone sunscreen. Danish pharmaceutical company Novo Nordisk (NYSE: NVO  ) , on the other hand, has focused primarily on selling products that treat diabetes.

In the following video, Motley Fool Rule Breakers analyst Simon Erickson and health-care bureau chief Max Macaluso discuss the pros and cons of such a focused strategy. They also look at ways Novo is trying to expand its business into new therapeutic areas, including obesity.

The Motley Fool's top stock for 2014
The market stormed out to huge gains across 2013, leaving investors on the sidelines burned. However, opportunistic investors can still find huge winners. The Motley Fool's chief investment officer has just hand-picked one such opportunity in our new report: "The Motley Fool's Top Stock for 2014." To find out which stock it is and read our in-depth report, simply click here. It's free!

Read/Post Comments (1) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On November 26, 2013, at 10:12 PM, PharmTeam wrote:

    Great video, Max. I'm curious if you guys have ever looked at recent IPO Veeva at all. It's another cloud-based healthcare IT that focuses on improving pharma SG&A efficiency, as well as data-sharing for multi-site trials.

Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2743505, ~/Articles/ArticleHandler.aspx, 9/30/2016 1:05:13 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,325.00 181.55 1.00%
S&P 500 2,170.15 19.02 0.88%
NASD 5,315.79 46.63 0.89%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/30/2016 12:49 PM
NVO $41.69 Down -0.11 -0.26%
Novo Nordisk CAPS Rating: *****
JNJ $118.37 Up +1.10 +0.94%
Johnson and Johnso… CAPS Rating: *****
LLY $80.27 Up +0.53 +0.67%
Eli Lilly and Co. CAPS Rating: ***
MNKD $0.61 Up +0.01 +1.77%
MannKind CAPS Rating: *
MRK $62.45 Up +0.54 +0.86%
Merck and Co. CAPS Rating: ****